ES2072373T3 - Derivados de 3,5-dihidroimidazo(2,1-b)quinazolin-2(1h)-ona con propiedades inotropicas y lusitropicas positivas. - Google Patents

Derivados de 3,5-dihidroimidazo(2,1-b)quinazolin-2(1h)-ona con propiedades inotropicas y lusitropicas positivas.

Info

Publication number
ES2072373T3
ES2072373T3 ES90201745T ES90201745T ES2072373T3 ES 2072373 T3 ES2072373 T3 ES 2072373T3 ES 90201745 T ES90201745 T ES 90201745T ES 90201745 T ES90201745 T ES 90201745T ES 2072373 T3 ES2072373 T3 ES 2072373T3
Authority
ES
Spain
Prior art keywords
6alkyl
hydrogen
dihydroimidazo
quinazolin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90201745T
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Alfons Herman Marg Raeymaekers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2072373T3 publication Critical patent/ES2072373T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0892—Compounds with a Si-O-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

DERIVADOS 3,5-DIHIDROIMIDAZO[2,1-B]QUINAZOLINA-2(1H)-ONA INOTROPICO Y LUSITROPICO POSITIVOS DE LA FORMULA SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES Y FORMAS ESTEREOQUIMICAMENTE ISOMERAS DE ELLAS, EN DONDE R ES HIDROGENO, ALQUILO C1-6, FENILO, FENILO SUSTITUIDO, PIRIDINILO, O TIENILO OPCIONALMENTE SUSTITUIDO CON HALOGENO O ALQUILO C1-6; R1 ES HIDROGENO O ALQUILO C1-6; R2 ES HIDROGENO, ALQUILO C1-6, HIDROXI ALQUILO C1-6 O FENILO; O R1 Y R2 TOMADOS JUNTOS PUEDEN FORMAR TAMBIEN UN RADICAL ALCANODIILO C1-5; X ES UN RADICAL DE FORMULA = O (A), = N-O-R3 (B), O = CH-R4 (C); R3 ES HIDROGENO, TRI(ALQUILO C1-6)SILILO O ALQUILO C1-6 OPCIONALMENTE SUSTITUIDO CON COOH, COO ALQUILO C1-4, CONR5R6 O COOCH2CONR7R8; R4 ES COOH, COO ALQUILO C1-4, CONR5R6, COOCH2CONR7R8 O ALQUILO C1-6 OPCIONALMENTE SUSTITUIDO CON COOH, COO ALQUILO C1-4, CONR5R6 O COOCH2CONR7R8. COMPOSICIONES FARMACEUTICAS QUE CONTIENEN DICHO COMPUESTO COMO UN INGREDIENTE ACTIVO. METODOS DE PREPARAR DICHO COMPUESTO Y COMPOSICIONES FARMACEUTICAS.
ES90201745T 1989-07-07 1990-07-02 Derivados de 3,5-dihidroimidazo(2,1-b)quinazolin-2(1h)-ona con propiedades inotropicas y lusitropicas positivas. Expired - Lifetime ES2072373T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89201810 1989-07-07
US38133889A 1989-07-18 1989-07-18

Publications (1)

Publication Number Publication Date
ES2072373T3 true ES2072373T3 (es) 1995-07-16

Family

ID=26121192

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90201745T Expired - Lifetime ES2072373T3 (es) 1989-07-07 1990-07-02 Derivados de 3,5-dihidroimidazo(2,1-b)quinazolin-2(1h)-ona con propiedades inotropicas y lusitropicas positivas.

Country Status (18)

Country Link
EP (1) EP0406958B1 (es)
JP (1) JPH0363277A (es)
KR (1) KR910002857A (es)
AT (1) ATE119902T1 (es)
AU (1) AU623539B2 (es)
CA (1) CA2020630A1 (es)
DE (1) DE69017773T2 (es)
DK (1) DK0406958T3 (es)
ES (1) ES2072373T3 (es)
FI (1) FI93361C (es)
HU (1) HUT55395A (es)
IE (1) IE65781B1 (es)
IL (1) IL94978A (es)
NO (1) NO173870C (es)
NZ (1) NZ234186A (es)
PH (1) PH27111A (es)
PT (1) PT94616B (es)
RU (1) RU2057753C1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120845A (en) * 1989-07-18 1992-06-09 Janssen Pharmaceutica N.V. Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives
JPH05271200A (ja) * 1991-05-22 1993-10-19 Egyt Gyogyszervegyeszeti Gyar ６，７−ジクロロ−１，５−ジヒドロ−イミダゾ〔２，１−ｂ〕キナゾリン−２〔３Ｈ〕−オンの製造方法
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
FR2689012A1 (fr) * 1992-03-27 1993-10-01 Beecham Laboratoires Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires.
TW593317B (en) * 1993-06-21 2004-06-21 Janssen Pharmaceutica Nv Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
KR100347215B1 (ko) * 1994-03-07 2002-10-31 주식회사 삼영건설기술공사 고강도구조보강나선관
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
NZ516259A (en) 1999-05-28 2004-02-27 Virco N New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
AU2002226316B2 (en) 2000-10-20 2008-06-26 Virco Bvba Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8426429B2 (en) 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8383637B2 (en) 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) * 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
ES2360957T3 (es) 2005-10-25 2011-06-10 Janssen Pharmaceutica Nv Derivados de 2-amino-3,4-dihidro-pirido(3,4-d)-pirimidina utiles como inhibidores de la beta-secretasa (bace).
RU2008122978A (ru) 2005-11-09 2009-12-20 Комбинаторкс, Инкорпорейтед (Us) Способы, композиции и наборы для лечения медицинских состояний
US7776882B2 (en) 2006-02-06 2010-08-17 Baxter Ellen W 2-amino-3,4-dihydro-quinoline derivatives useful as inhibitors of β-secretase (BACE)
US7868022B2 (en) 2006-02-06 2011-01-11 Janssen Pharmaceutica Nv 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)
US7932261B2 (en) 2006-02-06 2011-04-26 Janssen Pharmaceutica Nv Macrocycle derivatives useful as inhibitors of β-secretase (BACE)
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
CA2713998A1 (en) 2008-01-28 2009-08-06 Janssen Pharmaceutica N.V. 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of.beta.-secretase (bace)
WO2009097401A1 (en) 2008-01-29 2009-08-06 Janssen Pharmaceutica N.V. 2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
GB0808950D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808953D0 (en) * 2008-05-16 2008-06-25 Shire Llc substituted quinazolines
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
MX2016001714A (es) 2013-08-09 2016-10-03 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides

Also Published As

Publication number Publication date
NO173870C (no) 1994-02-16
NO173870B (no) 1993-11-08
JPH0363277A (ja) 1991-03-19
NO903033D0 (no) 1990-07-06
RU2057753C1 (ru) 1996-04-10
IE902469A1 (en) 1991-02-13
FI93361C (fi) 1995-03-27
IE65781B1 (en) 1995-11-15
HUT55395A (en) 1991-05-28
PT94616B (pt) 1997-02-28
IL94978A (en) 1994-06-24
KR910002857A (ko) 1991-02-26
PH27111A (en) 1993-03-16
AU5879890A (en) 1991-01-10
EP0406958A2 (en) 1991-01-09
NZ234186A (en) 1991-10-25
DE69017773T2 (de) 1995-07-13
FI93361B (fi) 1994-12-15
FI903428A0 (fi) 1990-07-06
ATE119902T1 (de) 1995-04-15
CA2020630A1 (en) 1991-01-08
EP0406958A3 (en) 1991-09-25
HU904118D0 (en) 1990-12-28
DK0406958T3 (da) 1995-04-03
PT94616A (pt) 1991-03-20
AU623539B2 (en) 1992-05-14
IL94978A0 (en) 1991-06-10
NO903033L (no) 1991-01-08
EP0406958B1 (en) 1995-03-15
DE69017773D1 (de) 1995-04-20

Similar Documents

Publication Publication Date Title
ES2072373T3 (es) Derivados de 3,5-dihidroimidazo(2,1-b)quinazolin-2(1h)-ona con propiedades inotropicas y lusitropicas positivas.
AU588890B2 (en) (4-Piperidinylmethyl and - hetero) Purines
AU593736B2 (en) Novel intermediates
AU630575B2 (en) Benzodiazepine derivatives
DE69001004T2 (de) Zusammensetzung gegen leberkrankheiten.
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 406958

Country of ref document: ES